Volume 21, Number 11—November 2015
Dispatch
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Figure 1
![Age-specific incidence of invasive pneumococcal disease caused by any serotype of Streptococcus pneumoniae per epidemiologic year (June–May), the Netherlands. Vertical dashed lines indicate introduction of 7-valent pneumococcal conjugate vaccine in June 2006 and 10-valent pneumococcal conjugate vaccine in May 2011. Incidences are based on sentinel surveillance data and extrapolated to the national level.](/eid/images/14-0780-F1.jpg)
Figure 1. Age-specific incidence of invasive pneumococcal disease caused by any serotype of Streptococcus pneumoniae per epidemiologic year (June–May), the Netherlands. Vertical dashed lines indicate introduction of 7-valent pneumococcal conjugate vaccine in June 2006 and 10-valent pneumococcal conjugate vaccine in May 2011. Incidences are based on sentinel surveillance data and extrapolated to the national level.
Page created: November 03, 2015
Page updated: November 03, 2015
Page reviewed: November 03, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.